Novel measures of cardiovascular health and its association with prevalence and progression of age-related macular degeneration: The CHARM study

BMC Ophthalmology

Volumn 8, Issue , 2008, Pages

  McCarty, Catherine A ^a,b   Dowrick, Adam ^a,c   Cameron, James ^a   McGrath, Barry ^c   Robman, Luba D ^b   Dimitrov, Peter ^b   Tikellis, Gabriella ^b   Nicolas, Caroline ^b   McNeil, John ^c   Guymer, Robyn ^b  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC SYSTEM; AGED; ARTERY; ARTICLE; AUSTRALIA; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CAROTID ARTERY; DISEASE COURSE; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; PULSE RATE; RETINA MACULA DEGENERATION; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; ARTERIES; AUSTRALIA; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CAROTID ARTERIES; DISEASE PROGRESSION; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PREVALENCE; PULSE; RISK ASSESSMENT; RISK FACTORS; VASOMOTOR SYSTEM;

EID: 58349088511     PISSN: None     EISSN: 14712415     Source Type: Journal    
DOI: 10.1186/1471-2415-8-25     Document Type: Article

References (59)

1. Vision Problems in the U.S. Prevalence of Adult Vision Impairment and Age-related Eye Disease in America Schaumberg, IL: Prevent Blindness America 2002
2. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia. The Visual Impairment Project. MR VanNewkirk L Weih CA McCarty HR Taylor, Ophthalmology 2001 108 960 967 10.1016/S0161-6420(01)00554-1 11320028
3. The prevalence of age-related maculopathy: the Visual Impairment Project. MR VanNewkirk MB Nanjan JJ Wang P Mitchell HR Taylor CA McCarty, Ophthalmology 2000 107 1593 1600 10.1016/S0161-6420(00)00175-5 10919916
4. Smoking and age-related macular degeneration: a review of association. J Thorton R Edwards P Mitchell RA Harrison I Buchan SP Kelly, Eye 2005 19 935 944 10.1038/sj.eye.6701978 16151432
5. Smoking is a major cause of blindness. A new cigarette pack warning? P Mitchell S Chapman W Smith, Med J Aust 1999 171 173 174 10494230
6. Systemic hypertension and age-related maculopathy in the Framingham Study. RD Sperduto R Hiller, Arch Ophthalmol 1986 104 216 219 3947296
7. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. R Klein BEK Klein T Franke, Ophthalmology 1993 100 406 414 8460013
8. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. JR Vingerling I Dielemans ML Bots A Hofman DE Grobbee PTVM de Jong, Am J Epidemiol 1995 142 404 409 7625405
9. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy. The Blue Mountains Eye Study. W Smith P Mitchell SR Leeder JJ Wang, Arch Ophthalmol 1998 116 583 587 9596493
10. Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. C Delcourt F Michel A Colvez A Lacroux M Delage M-H Vernet POLA Study Group, Ophthalmic Epidemiol 2001 8 237 249 10.1076/opep.8.4.237.1613 11471092
11. Hypertension, cardiovascular disease, and age-related macular degeneration. L Hyman AP Schachat Q He MC Leske Age-Related Macular Degeneration Risk Factors Study Group, Arch Ophthalmol 2000 118 3 351 358 10721957
12. Do age-related macular degeneration and cardiovascular disease share common antecedents? KK Snow JM Seddon, Ophthalmic Epidemiol 1999 6 125 143 10.1076/opep.6.2.125.1558 10420212
13. The relation of cardiovascular disease and its risk factors to the five year incidence of age-related maculopathy: The Beaver Dam Eye Study. R Klein BEK Klein SC Jensen, Ophthalmology 1997 104 1804 1812 9373110
14. The association of cardiovascular disease with the long-term incidence of age-related maculopathy. R Klein B Klein SC Tomany KJ Cruickshanks, Ophthalmology 2003 110 1273 1280 10.1016/S0161-6420(03)00599-2 12799274
15. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. R van Leeuwen MK Ikram JR Vingerling JCM Witteman A Hofman PTVM de Jong, Invest Ophthalmol Vis Sci 2003 44 3771 3777 10.1167/iovs.03-0121 12939290
16. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. E Friedman, Am J Ophthalmol 2000 130 658 663 10.1016/S0002-9394(00)00643-7 11078846
17. The effect of age on vascular compliance in man: which are the appropriate measures? CJ Bulpitt JD Cameron C Rajkumar S Armstrong M Connor J Joshi D Lyons O Moioli P Nihoyannopoulos, J Hum Hypertens 1999 13 753 758 10.1038/sj.jhh.1000879 10578219
18. Arterial stiffness and prediction of cardiovascular risk. BA Kingwell CD Gatzka, J Hypertens 2002 20 2337 2340 10.1097/00004872-200212000-00006 12473851
19. Assessment of large artery function. JD Cameron CD Gatzka BA Kingwell, Coronary Artery Dis 2002 13 405 413 10.1097/00019501-200212000-00004
20. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. A longitudinal study. P Boutouyrie AI Tropeano R Asmar I Gautier A Benetos P Lacolley S Laurent, Hypertension 2002 39 10 15 10.1161/hy0102.099031 11799071
21. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. R Asmar A Rudnichi J Blacher GM London ME Safar, Am J Hypertens 2001 14 183 185 10.1016/S0895-7061(00)01309-1 11243311
22. Pulse pressure. A predictor of long-term cardiovascular mortality in French male population. A Benetos M Safar A Rudnichi H Smulyan J-L Richard P Ducimetière L Guize, Hypertension 1997 30 1410 1415 9403561
23. Pulse pressure and cardiovascular mortality in normotensive and hypertensive patients. A Benetos A Rudnichi M Safar L Guize, Hypertension 1998 32 560 564 9740626
24. Augmentation index is associated with cardiovascular risk. J Nürnberger A Keflioglu-Scheiber AMO Saez RR Wenzel T Philipp RF Schäfers, J Hypertension 2002 20 2407 2414 10.1097/00004872-200212000-00020
25. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance. An integrated index of vascular function? K Cruickshank L Riste SG Anderson JS Wright G Dunn RG Gosling, Circulation 2002 106 2085 2090 10.1161/01.CIR.0000033824.02722.F7 12379578
26. The relationship between arterial compliance, age, blood pressure and serum lipid levels. JD Cameron GL Jennings AM Dart, J Hypertens 1995 13 12 Pt 2 1718 1723 8903639
27. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. A Simon J Gariepy G Chironi J-L Megnien J Levenson, J Hypertens 2002 20 159 169 10.1097/00004872-200202000-00001 11821696
28. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. DH O'Leary JF Polak, Am J Cardiol 2002 90 suppl 18L 21L 10.1016/S0002-9149(02)02957-0
29. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. E de Groot GK Hovingh A Wiegman P Duriez AJ Smit J-C Fruchart JJP Kastelein, Circulation 2004 109 23 Suppl 1 III33 III38 15198964
30. Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) Study. L Robman J McNeil P Dimitrov A Dowrick G Tikellis C Nicolas J Cameron R Guymer B McGrath C McCarty, Ophthalmic Epidemiol 2004 11 161 179 10.1080/09286580490514469 15370549
31. Methods for a population-based study of eye disease: the Melbourne Visual Impairment Project. PM Livingston CA Carson YL Stanislavsky SE Lee CS Guest HR Taylor, Ophthalmic Epidemiol 1994 1 139 148 10.3109/09286589409047222 8790620
32. Baseline ophthalmic findings in the Vitamin E, Cataract and Age-related Maculopathy study. LD Robman G Tikellis SKM Garrett CA Harper JJ McNeil HR Taylor CA McCarty, Aust N Z J Ophthalmol 1999 27 6 410 416 10.1046/j.1440-1606. 1999.00240.x 10641899
33. The VECAT Study: methodology and statistical power for measurement of age-related macular features. G Tikellis LD Robman CA Harper SKM Garrett JJ McNeil HR Taylor CA McCarty, Ophthalmic Epidemiol 1999 6 181 194 10.1076/opep.6.3.181.1502 10487973
34. Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy. SKM Garrett JJ McNeil C Silagy M Sinclair AP Thomas LD Robman CA McCarty G Tikellis HR Taylor, Ophthalmic Epidemiol 1999 6 195 208 10.1076/opep.6.3.195.1500 10487974
35. An international classification and grading system for age-related maculopathy and age-related macular degeneration. International ARM Epidemiological Study Group, Surv Ophthalmol 1995 39 367 374 10.1016/S0039-6257(05)80092-X 7604360
36. Vitamin E supplementation and macular degeneration: randomized controlled trial. HR Taylor G Tikellis LD Robman CA McCarty JJ McNeil, BMJ 2002 325 7354 1 2 12098707 10.1136/bmj.325.7354.11
37. The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. A Hodge AJ Patterson WJ Brown P Ireland G Giles, Aust NZ J Public Health 2000 24 576 583 10.1111/j.1467-842X.2000.tb00520.x
38. Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size. Y-L Liang H Teede D Kotsopoulos L Shiel JD Cameron AM Dart BP McGrath, Clinical Scie 1998 95 669 679 10.1042/CS19980148
39. Comparison of 3 fundus cameras for detecting features related to early age-related macular degeneration. (Abstract). G Tikellis L Robman R Guymer C McCarty, Clin Exper Ophthalmol 2002 30 Suppl A254
40. Characteristics of early age-related macular degeneration: the Cardiovascular Health and Age-related Maculopathy Study. G Tikellis LD Robman P Dimitrov C Nicolas CA McCarty RH Guymer, Eye 2007 21 169 176 10.1038/sj.eye.6702151 16732219
41. J Sambrook EF Fritsch T Maniatis, Molecular Cloning: a Laboratory Manual Cold Spring Harbor Press 1989
42. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. PN Baird E Guida DT Chu HT Vu RH Guymer, Invest Ophthalmol Vis Sci 2004 45 1311 1315 10.1167/iovs.03-1121 15111582
43. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. JE Eichner ST Dunn G Perveen DM Thompson KE Stewart BC Stroehla, Am J Epidemiol 2002 155 487 495 10.1093/aje/155.6.487 11882522
44. Genetic susceptibility to age related macular degeneration. JRW Yates AT Moore, J Med Genet 2000 37 83 87 10662806 10.1136/jmg.37.2.83
45. The apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD). PN Baird AJ Richardson LD Robman PN Dimitrov G Tikellis CA McCarty RH Guymer, Human Mutation 2006 27 337 342 10.1002/humu.20288 16453339
46. Estimation of arterial mechanics in clinical practice and as a research technique. J Cameron, Clin Exper Pharm Physiol 1999 26 285 294 10.1046/j.1440-1681.1999.03032.x
47. Early age-related maculopathy in the Cardiovascular Health Study. R Klein BEK Klein EK Marino LH Kuller C Furberg GL Burke LD Hubbard, Ophthalmology 2003 110 25 33 10.1016/S0161-6420(02)01565-8 12511342
48. Pathogenesis of diabetic retinopathy - the missing link. D Verma, Med Hypotheses 1993 41 205 210 10.1016/0306-9877(93)90231-E 7505046
49. Modifying factors related to asymmetric diabetic retinopathy. M Dogru M Inoue M Nakamura M Yamamoto, Eye 1998 12 929 933 10325988
50. Age-related eye disease and survival. The Beaver Dam Eye Study. R Klein BE Klein SE Moss, Arch Ophthalmol 1995 113 333 339 7887847
51. Vision impairment predicts 5 year mortality. CA McCarty MB Nanjan HR Taylor, Br J Ophthalmol 2001 85 322 326 11222339 10.1136/bjo.85.3.322
52. A hemodynamic model of the pathogenesis of age-related macular degeneration. E Friedman, Am J Ophthalmol 1997 124 677 682 9372722
53. Update of the vascular model of AMD. Are statins or antihypertensives protective? E Friedman, Br J Ophthalmol 2004 88 161 163 14736760 10.1136/bjo.2003.036277
54. Heritability of carotid artery structure and function. The Strong Heart Family Study. KE North JW MacCluer RB Devereux BV Howard TK Welty LG Best ET Lee RR Fabsitz MJ Roman Strong Heart Family Study, Arterioscler Thromb Vasc Biol 2002 22 1698 1703 10.1161/01.ATV.0000032656.91352.5E 12377752
55. Influence of angiotensin-converting enzyme and angiotensein II type I receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. A Benetos S Gautier S Ricard J Topouchian R Asmar O Poirier E Larosa L Guize M Safar F Soubrier F Cambien, Circulation 1996 94 698 703 8772690
56. Angiotensin-converting enzyme gene polymorphism and common carotid stiffness. The Rotterdam Study. FU Mattace-Raso TJ van der Cammen FA Sayed-Tabatabaei NM van Pop R Asmar MA Schalekamp R Asmar A Hofman JC Witteman, Atherosclerosis 2004 174 121 126 10.1016/j.atherosclerosis.2004.01.012 15135260
57. Fibrillin-1 genotype is associated with aortic stiffness and disease severity in patients with coronary artery disease. TL Medley TJ Cole CD Gatzka WYS Wang AM Dart BA Kingwell, Circulation 2002 105 810 815 10.1161/hc0702.104129 11854120
58. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. TL Medley BA Kingwell CD Gatzka P Pillay TJ Cole, Circ Res 2003 92 1254 1261 10.1161/01.RES.0000076891.24317.CA 12750310
59. Nitric oxide synthase gene polymorphism (G894T) influences arterial stiffness in adults: the Bogalusa Heart Study. W Chen SR Srinivasan MG Bond R Tang EM Urbina S Li E Boerwinkle GS Berenson, Am J Hypertens 2004 17 553 559 10.1016/j.amjhyper.2004.02.021 15233973